Tag: tolerability

Bar chart showing shift in obesity drug development priorities from maximum weight loss to tolerability and persistence metrics
Clinical UpdatesNew StudiesPracticeResearch Digest

Obesity Drug Development Shifts Focus: Tolerability and Persistence Over Maximum Weight Loss

Pharmaceutical developers are deprioritizing maximum weight loss in favour of tolerability, persistence, and sustainable benefits in obesity pharmacotherapy. According to…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network